Join the Optical Fibers and Sensors for Medical Diagnostics, Treatment and Environmental Applications XXV conference for this panel discussion. Navigating a complex regulatory landscape and developing effective market entry strategies are critical challenges for startups in the optical technologies sector. This panel will bring together experts from regulatory agencies, industry leaders, and experienced entrepreneurs to discuss unique regulatory pathways and commercialization strategies for optical innovations in the biomedical field. Attendees will gain insights into the U.S. FDA approval process and the latest trends in regulatory science that impact optical technologies. In addition, this session will provide guidance on market access strategies, such as engaging with key opinion leaders and leveraging partnerships for distribution and commercialization. The goal of this panel is to discuss practical tools and share knowledge to help startups successfully bring their optical innovations to market.

Moderators:
Katy Roodenko, Max-IR Labs., LLC
Israel Gannot, Tel Aviv Univ.

Panelists:
Viacheslav G. Artyushenko, art photonics GmbH
Mathias Belz, Lytegate GmbH
Ilko K. Ilev, U.S. Food and Drug Administration
Devinder Saini, Molex, LLC
Gary Spingarn, Hamamatsu Corp.
James Clarkin, WEINERT Fiber Optics GmbH

Event Details

FORMAT: Panel discussion followed by audience Q&A.
MENU: Coffee, decaf, and tea will be available outside the presentation room.
SETUP: Classroom and theater style seating.